Ls Investment Advisors, LLC Bei Gene, Ltd. Transaction History

Ls Investment Advisors, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 10, 2020	SELL	$123.9 - $195.41 $8,920 - $14,069	-72 Closed	0 $0
Q1 2020 Apr 20, 2020	SELL	$121.84 - $173.19 $54,584 - $77,589	-448 Reduced 86.15%	72 $9,000
Q4 2019 Jan 31, 2020	BUY	$115.78 - $208.34 $1,968 - $3,541	17 Added 3.38%	520 $86,000
Q4 2018 Feb 01, 2019	BUY	$107.01 - $175.15 $53,826 - $88,100	503 New	503 $71,000

252

45.3M

292K

119K

Ticker BGNE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 103,700,000
Market Cap $21.4B
Description
BeiGene, Ltd., a biotechnology company, focuses on discovering, developing, manufacturing, and commercializing various medicines worldwide. Its products include BRUKINSA to treat relapsed/refractory (R/R) mantle cell lymphoma; Tislelizumab to treat R/R classical Hodgkin's lymphoma; REVLIMID to treat multiple myeloma; VIDAZA to treat myelodysplas...

Get notified when there are updates to the investment portfolio of Ls Investment Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Ls Investment Advisors, LLC with notifications on news.